Story

OMX Copenhagen 20 Jumps 1.45% to 3-Month High, Led by Zealand Pharma

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
OMX Copenhagen 20 Jumps 1.45% to 3-Month High, Led by Zealand Pharma

Summary

Denmark's benchmark stock index closed at its highest level in three months on Wednesday, gaining 1.45% on the back of strong performances from healthcare and consumer goods companies.

Text size
Background

Danish stocks advanced on Wednesday, with the benchmark OMX Copenhagen 20 index closing up 1.45% to reach its highest level in three months. The rally was primarily fueled by strong performance in the healthcare, consumer goods, and chemicals sectors.

Session Highlights

The broad-based advance on the Copenhagen Stock Exchange saw 72 stocks rise compared to 44 that declined, while 20 ended the session unchanged, according to market data. The positive close indicates solid investor sentiment driving the main index to a new quarterly peak.

Top Movers

Healthcare and pharmaceutical companies were among the day's most significant gainers, providing a major boost to the index.

Sample IUX Markets – In-articleAd
  • Zealand Pharma A/S (CSE:ZELA) was the top performer, surging 6.71% to close at 299.00.
  • Rockwool AS B (CSE:ROCKb), an industrial manufacturer, also posted a strong performance, adding 3.78%.
  • Healthcare giant Novo Nordisk A/S Class B (CSE:NOVOb), a key index component, rose 3.39%.

On the downside, some financial and industrial names faced selling pressure. Tryg A/S (CSE:TRYG) was the worst performer on the index, falling 1.03%, followed by Danske Bank A/S (CSE:DANSKE) which declined 1.01%.

Broader Market Context

The gains in Danish equities came amid a slight downturn in global commodity markets. Brent crude, the international oil benchmark, fell approximately 1.37% for September delivery. In currency markets, the Danish Krone strengthened against the U.S. dollar, with the USD/DKK pair declining by about 0.16%.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST